197 related articles for article (PubMed ID: 8874974)
21. In vitro activity of cefoperazone-sulbactam: Singapore experience.
Kumarasinghe G; Chow C; Chiu C; Cheong YM
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):734-7. PubMed ID: 9253876
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
23. Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Eltahawy AT
J Chemother; 1997 Dec; 9(6):403-10. PubMed ID: 9491839
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015].
Hao D; Hu Z; Liu X; Sun T; Wang T; Tian H; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):439-44. PubMed ID: 29920041
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of cefoperazone-sulbactam combination against gram negative bacilli.
Poudyal N; Gyawali N; Gurung R; Bhattarai NR; Baral R; Khanal B; Shrestha S; Amatya R; Bhattacharya SK
Nepal Med Coll J; 2012 Mar; 14(1):5-8. PubMed ID: 23441486
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam.
Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS
Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280
[TBL] [Abstract][Full Text] [Related]
27. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Spencer RC
Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
[TBL] [Abstract][Full Text] [Related]
28. In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone.
Chandrasekar PH; Sluchak JA
Infection; 1991; 19(1):49-53. PubMed ID: 2013510
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone.
Lee K; Lee HS; Jang SJ; Park AJ; Lee MH; Song WK; Chong Y;
J Korean Med Sci; 2001 Jun; 16(3):262-70. PubMed ID: 11447969
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
Itokazu GS; Quinn JP; Bell-Dixon C; Kahan FM; Weinstein RA
Clin Infect Dis; 1996 Oct; 23(4):779-84. PubMed ID: 8909844
[TBL] [Abstract][Full Text] [Related]
31. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
32. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
Le Noc P; Robert J; Le Noc D
Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
[TBL] [Abstract][Full Text] [Related]
33. In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients.
Bodey GP; Miller P; Ho DH
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):209S-214S. PubMed ID: 2591178
[TBL] [Abstract][Full Text] [Related]
34. Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units.
Liu PY; Lau YJ; Hu BS; Shyr JM; Shi ZY; Tsai WS; Lin YH; Tseng CY
Diagn Microbiol Infect Dis; 1995 Jul; 22(3):285-91. PubMed ID: 8565418
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
Neu HC; Chin NX; Saha G; Labthavikul P
Antimicrob Agents Chemother; 1986 Dec; 30(6):828-34. PubMed ID: 3545068
[TBL] [Abstract][Full Text] [Related]
36. [The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
Maesaki S; Yamaguchi T; Sasaki K; Hashikita G; Shibuya S; Watanabe M; Takayama S; Kawakami S; Nagasawa M; Suzuki N; Uchida T; Okabe T; Kobayashi S;
Jpn J Antibiot; 2006 Feb; 59(1):11-20. PubMed ID: 16673578
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
[TBL] [Abstract][Full Text] [Related]
38. Comparative in vitro evaluation of piperacillin/tazobactam in a tertiary care hospital.
Platsouka E; Zissis NP; Constantoulaki S; Paniara O
J Chemother; 1997 Oct; 9(5):336-40. PubMed ID: 9373788
[TBL] [Abstract][Full Text] [Related]
39. Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
Zemelman R; Bello H; Dominguez M; Gonzalez G; Mella S; Garcia A
J Antimicrob Chemother; 1993 Sep; 32(3):413-9. PubMed ID: 8262863
[TBL] [Abstract][Full Text] [Related]
40. Comparison of in vitro activities of ceftazidime, piperacillin-tazobactam, and cefoperazone-sulbactam, and the implication on empirical therapy in patients with cancer.
Prabhash K; Medhekar A; Biswas S; Kurkure P; Nair R; Kelkar R
Indian J Cancer; 2009; 46(4):318-22. PubMed ID: 19749462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
